The impact of nutrition on depression

19th Oct 2023

Depression:

Major depressive disorder (MDD) is the most predominant illness amongst mental, neurological and substance abuse disorders(1), with a lifetime prevalence of at least 10% and the risk in women twice that in men(2) . Research suggests that MDD is the most pervasive comorbid disorder to co-occur with generalised anxiety disorder (GAD), with a lifetime comorbidity rate of 90%(3).

Naturopathic and functional medicine explanation

Unravelling the multifactorial root causes of depression is challenging and looking at a broad amalgamation of unique factors such as vitamin D levels(4), gut microbiome diversity (5) amino acids and minerals(6), toxin exposure(7), mitochondrial dysfunction(8), inflammation(9), omega-3 polyunsaturated fatty acids (n-3FA)(10), diet(11)  and lifestyle factors alongside adrenal function, thyroid health(12), neurotransmitter signalling(13)  and blood sugar balance(14)  allows functional medicine to create a unique insight into depression.

Gut microbiome:

A bidirectional relationship between the gut and the brain, connected via the microbiota-gut-brain axis involves communication via endocrine, neural and immune pathways(15), to mediate key processes including neurotransmission, neuroinflammation, neurogenesis and activation of the hypothalamic-pituitary-adrenal (HPA) axis(16) . Researchers indicate via MRI, the gut microbiome composition is correlated with neural activity and brain structure(17). The gut microbiota profiles of those with depression have shown a narrowing microbial diversity(16).

Vitamin D:

A wealth of research indicates lower vitamin D levels are associated with both minor and major depression alongside depressive symptoms in a range of ages from 18(18) to the elderly population, finding those with severe vitamin D deficiency were twice as likely to have depression(19) .  Vitamin D has shown to have a neuroprotective role in the brain(20) and modulates the HPA axis, regulating the synthesis of dopamine, adrenaline and noradrenalin through vitamin D receptors in the adrenal cortex(21), leading to alterations in mood. Furthermore, vitamin D has shown to protect against dopamine and serotonin centrally(22).

Diet:

Fibre from fruit, vegetables, legumes and wholegrains have shown to be beneficial to those with depression, modulating the gut microbiome(23) and promoting immune functioning(24). Furthermore, phytochemicals found in wholegrains are protective against oxidative stress, which may be a result of inflammation found in those with depression(25). Refined sugary, high fat diets which lack dietary fibre not only impact the gut microbiome and immune function but also reduces Brain derived neurotrophic factor (BDNF), neuronal plasticity and learning within the hippocampus, which has been linked to depression(26).

A wealth of evidence supports the traditional Mediterranean diet (TMD) as a treatment for depression, characterized by low intakes of red meat, processed foods and confectionaries; with focus on a high intake of plant foods (legumes, fruit, vegetables, nuts , seeds, wholegrains, olives) a moderate intake of fish and extra virgin olive oil as the main intake of fat(27).  In addition, research provides compelling support for the use of a TMD alongside fish oil supplementation of 900mg DHA and 200mg EPA for 3 months, for treating depression(28). A 45% improvement in depression scores were reported in those who had a dietary intervention, in contrast to 26.8% in the control group.

A TMD is rich in polyphenols and fibre, supporting the gut microbiome diversity, reducing dysbiosis, thus supporting the immune function and reducing the activation of the inflammatory cascade(29) , which has shown to be linked to depression. Adherence to a TMD ensures adequate B vitamin intake, imperative for several methylation reactions, including neurotransmitter production(30).

Final thoughts:

 

Author: Hannah Frais

Nutritional therapist BSc (Hons), DipCNM, mBANT, mANP

 

 

 

 

References:

(1) Collins, P.Y. Patel, V. Joestl, S.S. et al. (2011). ‘Grand challenges in global mental health’, Nature, 475, pp.27-30.

(2) Weissman, M.M. Bland, R.C. Canino, G.J. et al. (1996). ‘Cross-national epidemiology of major depression and bipolar disorder’, JAMA, 276, pp.293-299.

(3) Wittchen, H.U. Zhao, S. Kessler, R.C. et al. (1994). ‘DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Archives of general psychiatry’, 51 (5), pp.355-364.

(4) Eyles, D.W. Burne, T.H.J. McGrath, J.J (2013). ‘Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease’, Front Neuroendocrinol, 34, pp.47-64.

(5) Dinan, T.G. Stilling, R.M. Stanton, C. et al. (2015). ‘Collective unconscious: How gut microbes shape human behavior’, J Psychiatr Res, 63, pp.1-9.

(6) Nasca, C. Bigio, B. Lee, F.S. et al. (2018). ‘Acetyl-l-carnitine deficiency in patients with major depressive disorder’, Proceedings of the National Academy of Sciences, 115 (34), pp.8627-8632.

(7) Freire, C. & Koifman, S. (2013). ‘Pesticides, depression and suicide: a systematic review of the epidemiological evidence’, International journal of hygiene and environmental health, 216 (4), pp.445-460.

(8) Gardner, A. & Boles, R.G. (2011). ‘Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders’, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35 (3), pp.730-743.

(9) Na, K.S. Lee, K.J. Lee, J.S. et al. (2014). ‘Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis’, Prog Neuropsychopharmacol Biol Psychiatry, 48, pp.79-85.

(10) Kiecolt-Glaser, J.K. Belury, M.A. Porter, K. et al. (2007). ‘Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults’, Psychosom Med, 69 (3), pp.217-224.

(11) Berk, M. Williams, L.J. Jacka, F.N. et al. (2013). ‘So depression is an inflammatory disease, but where does the inflammation come from?’, BMC Med, 11, pp.200.

(12) Musselman, D.L. & Nemeroff, C.B. (1996). ‘Depression and endocrine disorders: focus on the thyroid and adrenal system’, Br J Psychiatry Suppl, 30, pp.123-128.

(13) Raedler, T. (2011). ‘Inflammatory mechanisms in major depressive disorder’, Current Opinion in Psychiatry, 24, pp.519-525.

(14) Al-Amer, R.M. Sobeh, M.M. Zayed, A.A. et al. (2011). ‘Depression among adults with diabetes in Jordan: risk factors and relationship to blood sugar control’, Journal of Diabetes and its Complications, 25 (4), pp.247-252.

(15) Mayer, E.A. Knight, R. Mazmanian, S.K. et al. (2014). ‘Gut microbes and the brain: paradigm shift in neuroscience’, J. Neurosci, 34 (46), pp.15490-15496.

(16) Dinan, T.G. Stilling, R.M. Stanton, C. et al. (2015). ‘Collective unconscious: How gut microbes shape human behavior’, J Psychiatr Res, 63, pp.1-9.

(17) Fernandez-Real, J.M. Serino, M. Blasco, G. et al. (2015). ‘Gut Microbiota Interacts With Brain Microstructure and Function’, J Clin Endocrinol Metab, 100, pp.4505-4513.

(18) Jozefowicz, O. Rabe-Jablonska, J. Wozniacka, A. et al. (2014). ‘Analysis of vitamin D status in major depression’, Journal of Psychiatric Practice, 20 (5), pp.329-337.

(19) Lapid, M.I. Cha, S.S. Takahashi, P.Y. (2013). ‘Vitamin D and depression in geriatric primary care patients’, Clin Interv Aging, 8, pp.509-514.

(20) Anglin, R.E.S. Samaan, Z. Walter, S.D. et al. (2013). ‘Vitamin D deficiency and depression in adults: systematic review and meta-analysis’, Br J Psychiatry J Ment Sci, 202, pp.100.

(21) Puchacz, E. Stumpf, W. Stachowiak, E.K. et al. (1996). ‘Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells’, Mol. Brain Res, 36, pp.193-196.

(22) Cass, W.A. Smith, M.P. Peters, L.E. (2006). ‘Calcitriol protects against the dopamine and serotonin-depleting effects of neurotoxic doses of methamphetamine’, Ann N Y Acad Sci, 1074, pp.261-271.

(23) Tachon, S. Zhou, J. Keenan, M. (2013). ‘The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses’, FEMS Microbiol Ecol, 83, pp.299-309.

(24) Volman, J.J. Ramakers, J.D. Plat, J. (2008). ‘Dietary modulation of immune function by beta-glucans’, Physiol Behav, 94, pp.276-284.

(25) Bilici, M. Efe, H. Koroglu, M.A. et al. (2001) ‘Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments’, J Affect Disord, 64, pp.43-51.

(26) Molteni, R. Barnard, R.J. Ying, Z. et al. (2002). ‘A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning’, Neuroscience, 112 (4), pp.803-814.

(27) Bach-Faig, A. Berry, E.M. Lairon, D. et al. (2011). ‘Mediterranean diet pyramid today. Science and cultural updates’, Pub Health Nutr, 14 (12A), pp.2274-2278.

(28) Parletta, N. Milte, C.M. Meyer, B.J. (2013). ‘Nutritional modulation of cognitive function and mental health’, J Nutr Biochem, 24, pp.725-743.

(29) Edwards, C.A. Havlik, J. Cong, W. et al. (2017). ‘Polyphenolsand health: Interactions between fibre, plant polyphenols and the gut microbiota’, Nutr Bull, 42, pp.356-360.

(30) Sanchez-Villegas, A. Henriquez, P. Bes-Rastrollo, M. et al. (2006). ‘Mediterranean diet and depression’, Public Health Nutr, 9, pp.1104-1109.

(31) Toribio-Mateas, M. (2018). ‘Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions’, Microorganisms, 6 (2).

(32) Klinder, A. Shen, Q. Heppel, S. et al. (2016). ‘Impact of increasing fruit and vegetables and flavonoid intake on the human gut microbiota’, Food Funct, 7, pp.1788-1796.

(33) Mohammadi, A.A. Jazayeri, S. Khosravi-Darani, K. et al. (2016). ‘The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers’, Nutr Neurosci, 19, pp.387-395.